These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1713073)

  • 1. Enhanced detection systems for enzyme-linked heterogeneous immunoassays: luminescence.
    Edwards JC; Moon CR
    Immunol Ser; 1990; 53():95-106. PubMed ID: 1713073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for heterogeneous enzyme immunoassays for tumor markers.
    King WJ; Tomita JT; Dowell BL; Delfert DM
    Immunol Ser; 1990; 53():83-93. PubMed ID: 1713072
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma].
    Takakura N; Mimura H; Hamazaki K; Kim H; Hirata K; Miwata H; Kimura T; Sakata T; Hosoba T; Orita K
    Gan No Rinsho; 1987 Sep; 33(11):1385-90. PubMed ID: 2444728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor markers].
    Cappelaere P
    Rev Prat; 1988 Jun; 38(17):1058-63. PubMed ID: 2457249
    [No Abstract]   [Full Text] [Related]  

  • 5. [The level of embryonic antigens in the blood serum and cerebrospinal fluid of neuro-oncological patients].
    Rudenko VA; Lisianyĭ NI; Grinevich IuA; Burkatovskaia MB; Iugrinova LG
    Zh Vopr Neirokhir Im N N Burdenko; 1996; (3):32-5. PubMed ID: 8975514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinoembryonic antigen, alpha-fetoprotein and human chorionic gonadotropin producing gastric cancer].
    Honda T; Katusima S; Tokuda Y; Matuda K; Oonisi Y; Taniguchi T; Oomoto J; Kawaguchi Y
    Nihon Naika Gakkai Zasshi; 1984 Apr; 73(4):521-6. PubMed ID: 6206171
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gastric cancer with bone metastasis from the viewpoint on oncodevelopmental gene products].
    Ohyama S; Yonemura Y; Hashimoto T; Sawa T; Miwa K; Miyazaki I
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):1013-9. PubMed ID: 2447212
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumour markers.
    Pandha HS; Waxman J
    QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-linked heterogeneous immunoassays with electrochemical detection.
    Halsall HB; Jenkins SH; Heineman WR
    Immunol Ser; 1990; 53():107-24. PubMed ID: 2100550
    [No Abstract]   [Full Text] [Related]  

  • 11. Oncofetal and oncoplacental antigens as tumor markers.
    Yamauchi S; Miyake H
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-invasive cancer detection: strategies for the identification of novel cancer markers.
    Sorio C; Mauri P; Pederzoli P; Scarpa A
    IUBMB Life; 2006 Apr; 58(4):193-8. PubMed ID: 16754296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of a seminoma cell-line (S2).
    von Keitz AT; Riedmiller H; Neumann K; Gutschank W; Fonatsch C
    Investig Urol (Berl); 1994; 5():28-31. PubMed ID: 7536523
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum tumor markers.
    Klee GG; Go VL
    Mayo Clin Proc; 1982 Feb; 57(2):129-32. PubMed ID: 6172679
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tumor markers--possibilities and limitations].
    Rose H; Saul G; Wolf G; Moldenhauer H; Kehrberg G
    Radiobiol Radiother (Berl); 1984; 25(1):7-19. PubMed ID: 6203136
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serodiagnosis: tumor marker].
    Yoneshima M; Hattori N; Sawabu N
    Gan No Rinsho; 1988 Aug; 34(10):1209-15. PubMed ID: 2459425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biologic markers of cancer. Towards a selective use for the detection and surveillance of malignant tumors].
    Bellet D; Bidart JM
    Rev Prat; 1989 Nov; 39(26):2350-4. PubMed ID: 2480633
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
    Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A
    Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radioimmunoassays in oncology].
    Dressler J
    Fortschr Med; 1983 Mar; 101(11):451-4. PubMed ID: 6189774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of tumour markers in cancer diagnosis and treatment.
    Higgins C
    Nurs Times; 1996 Apr 17-23; 92(16):36-7. PubMed ID: 8710591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.